Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Jun-24 4:21 PM View:  | Atyr Pharma Inc (ATYR) | 30-May-24 | Private Purchase | 50,000 | $1.75 | $87,500.00 | 833% 6.0K to 56.0K | |
| 10-May-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-24 | Grant | 6,500 | -- | -- | 15% 42.5K to 49.0K | |
| 19-May-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-23 | Grant | 4,500 | -- | -- | 12% 38.0K to 42.5K | |
| 19-May-23 4:27 PM View: | Atyr Pharma Inc (ATYR) | 17-May-23 | Gift | 6,000 | -- | -- | 100% 6.0K to 12.0K | |
| 19-May-23 4:27 PM View: | Atyr Pharma Inc (ATYR) | 17-May-23 | Gift | 6,000 | -- | -- | (50%) 12.0K to 6.0K | |
| 28-Apr-23 4:51 PM View: | Atyr Pharma Inc (ATYR) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 13-Jun-22 4:39 PM View: | Fate Therapeutics Inc (FATE) | 09-Jun-22 | Grant | 8,650 | -- | -- | 15% 57.63K to 66.28K | |
| 06-Jun-22 4:43 PM View: | Fate Therapeutics Inc (FATE) | 03-Jun-22 | Sale | 1,439 | $22.81 | $32,823.60 | (2%) 59.07K to 57.63K | |
| 12-May-22 8:22 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Grant | 3,000 | -- | -- | 9% 35.0K to 38.0K | |
| 04-Jun-21 5:33 PM View: | Fate Therapeutics Inc (FATE) | 02-Jun-21 | Grant | 2,681 | -- | -- | 5% 56.39K to 59.07K | |
| 18-May-21 9:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-21 | Grant | 3,000 | -- | -- | 9% 32.0K to 35.0K | |
| 19-May-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-20 | Grant | 3,000 | -- | -- | 10% 29.0K to 32.0K | |
| 10-May-19 8:34 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-19 | Grant | 2,000 | -- | -- | 7% 27.0K to 29.0K | |
| 11-May-18 9:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-18 | Grant | 2,500 | -- | -- | 10% 24.5K to 27.0K | |
| 18-May-17 6:17 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-17 | Grant | 2,500 | -- | -- | 11% 22.0K to 24.5K | |
| 08-Feb-17 7:39 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-17 | Market Sale (Planned) | 963 | $43.14 | $41,543.80 | (< 1%) 138.92K to 137.96K | (168%) |
| 06-Feb-17 7:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Feb-17 | Market Sale (Planned) | 1,500 | $42.55 | $63,825.00 | (1%) 137.82K to 136.32K | (172%) |
| 18-Jan-17 6:45 PM View: | Neurocrine Biosciences Inc. (NBIX) | 17-Jan-17 | Market Sale (Planned) | 1,750 | $40.65 | $71,137.50 | (1%) 136.57K to 134.82K | (184%) |
| 12-Jan-17 6:59 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Jan-17 | Market Sale (Planned) | 1,750 | $43.37 | $75,897.50 | (1%) 134.87K to 133.12K | (167%) |
| 28-Nov-16 3:42 PM View: | Fate Therapeutics Inc (FATE) | 23-Nov-16 | Private Purchase | 56,390 | $2.66 | $149,997.00 | 100% 0 to 56.39K | |
| 19-May-16 1:32 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-May-16 | Grant | 2,000 | -- | -- | 10% 20.0K to 22.0K | |
| 04-Feb-16 7:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Feb-16 | Market Sale (Planned) | 1,500 | $38.06 | $57,090.00 | (1%) 132.87K to 131.37K | (204%) |
| 21-Jan-16 4:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Jan-16 | Market Sale (Planned) | 1,750 | $46.69 | $81,707.50 | (1%) 131.62K to 129.87K | (148%) |
| 13-Jan-16 6:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Jan-16 | Market Sale (Planned) | 1,750 | $44.25 | $77,437.50 | (1%) 129.87K to 128.12K | (161%) |
| 19-Oct-15 7:57 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Oct-15 | Market Sale (Planned) | 25,000 | $47.78 | $1,194,500.00 | (17%) 151.37K to 126.37K | (142%) |
| 21-Jul-15 8:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Jul-15 | Option Exercise | 20,000 | $5.76 | $115,200.00 | 20% 101.37K to 121.37K | |
| 21-Jul-15 8:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Jul-15 | Market Option Sale (Planned) | 20,000 | $55.00 | $1,100,000.00 | (16%) 121.37K to 101.37K | (110%) |
| 14-Jul-15 6:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Jul-15 | Option Exercise | 20,000 | $5.76 | $115,200.00 | 20% 101.37K to 121.37K | |
| 14-Jul-15 6:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Jul-15 | Market Option Sale (Planned) | 20,000 | $50.00 | $1,000,000.00 | (16%) 121.37K to 101.37K | (131%) |
| 10-Jun-15 5:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jun-15 | Option Exercise | 60,000 | $2.59 | $155,400.00 | 59% 101.37K to 161.37K | |
| 10-Jun-15 5:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jun-15 | Market Option Sale (Planned) | 60,000 | $45.08 | $2,704,800.00 | (37%) 161.37K to 101.37K | (157%) |
| 02-Apr-15 9:48 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Mar-15 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 24-Mar-15 6:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Mar-15 | Option Exercise | 40,000 | $2.59 | $103,600.00 | 39% 101.37K to 141.37K | |
| 24-Mar-15 6:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Mar-15 | Market Option Sale (Planned) | 40,000 | $44.49 | $1,779,600.00 | (28%) 141.37K to 101.37K | (160%) |
| 21-Jan-15 2:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Jan-15 | Market Sale (Planned) | 1,750 | $30.81 | $53,917.50 | (2%) 103.12K to 101.37K | (275%) |
| 13-Jan-15 6:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Jan-15 | Market Sale (Planned) | 1,750 | $28.37 | $49,647.50 | (2%) 101.37K to 99.62K | (308%) |
| 09-Jan-15 4:37 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-15 | Option Exercise | 10,000 | $2.59 | $25,900.00 | 10% 97.87K to 107.87K | |
| 09-Jan-15 4:37 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-15 | Market Option Sale (Planned) | 10,000 | $27.25 | $272,500.00 | (9%) 107.87K to 97.87K | (324%) |
| 19-Dec-14 7:01 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Dec-14 | Option Exercise | 10,000 | $2.59 | $25,900.00 | 10% 97.87K to 107.87K | |
| 19-Dec-14 7:01 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Dec-14 | Market Option Sale (Planned) | 10,000 | $24.02 | $240,200.00 | (9%) 107.87K to 97.87K | (381%) |
| 19-Dec-14 7:01 PM View: | Neurocrine Biosciences Inc. (NBIX) | 18-Dec-14 | Option Exercise | 20,000 | $2.59 | $51,800.00 | 20% 97.87K to 117.87K | |
| 19-Dec-14 7:01 PM View: | Neurocrine Biosciences Inc. (NBIX) | 18-Dec-14 | Market Option Sale (Planned) | 20,000 | $23.18 | $463,600.00 | (17%) 117.87K to 97.87K | (399%) |
| 12-Dec-14 5:48 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Dec-14 | Option Exercise | 20,000 | $3.86 | $77,100.00 | 20% 97.87K to 117.87K | |
| 12-Dec-14 5:48 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Dec-14 | Market Option Sale (Planned) | 20,000 | $21.48 | $429,500.00 | (17%) 117.87K to 97.87K | (438%) |
| 02-Dec-14 4:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Nov-14 | Market Sale (Planned) | 10,000 | $20.14 | $201,400.00 | (9%) 107.87K to 97.87K | (474%) |
| 03-Nov-14 6:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Oct-14 | Market Sale (Planned) | 10,000 | $19.00 | $190,000.00 | (9%) 107.87K to 97.87K | (509%) |
| 30-Oct-14 5:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 30-Oct-14 | Market Sale (Planned) | 10,000 | $18.62 | $186,200.00 | (9%) 107.87K to 97.87K | (521%) |
| 30-Oct-14 5:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Oct-14 | Market Sale (Planned) | 10,000 | $18.00 | $180,000.00 | (9%) 107.87K to 97.87K | (543%) |
| 13-Jan-14 6:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Jan-14 | Market Sale (Planned) | 1,750 | $18.56 | $32,480.00 | (2%) 99.62K to 97.87K | (524%) |
| 08-Jan-14 5:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Jan-14 | Market Sale (Planned) | 70,000 | $16.75 | $1,172,500.00 | (42%) 166.12K to 96.12K | (591%) |